Jeffrey Takimoto is the Chief Financial Officer & Chief Business Officer at Fuse Biotherapeutics. He was a former Chief Strategy Officer and CFO at NKMax America, Inc.
Jeffrey holds a PhD in Biology from the University of California, San Diego.
February 1, 2023 - present
June, 2021